Put your hand up if you are uninstalling WhatsApp?
Yes, from 8 February it appears that the tech giant gets access to a lot of our information, but, for those with Facebook accounts, they would already have this at hand, you would assume?
Lots of movements to signal and telegraph…
Too many messages!
Maybe we go back to no “smart phone”?
Across Markets…
Australian shares are poised to edge up with US benchmarks Dow and the S&P 500 trading modestly higher. The Nasdaq was higher, bolstered by tech shares.
ASX futures were up 10 points or 0.2 per cent to 6625 near 7am AEDT. The local currency slipped 0.4 per cent; the Bloomberg dollar spot index edged up 0.1 per cent.
The yield on the US 10-year note was 4 basis points lower to 1.09 per cent shortly after 3pm in New York.
In New York, stocks were modestly higher bolstered by a 7.9 per cent leap in Intel after the company unexpectedly replaced its chief executive. At about 3.08pm, the Dow was up just over 12 points.
Seven of the S&P 500's 11 industry groups were higher paced by utilities and real estate.
The Nasdaq pared earlier gains as big techs came off their session highs.
Source: AFR
CAR T cell treatment company Chimeric Therapeutics (ASX:CHM) is understood to have easily achieved its IPO fundraising target of $35m ahead of its ASX listing timed for Monday.
Institutional investors have expressed strong interest in the IPO priced at 20c per share, along with sophisticated investors, leading to the offer being heavily oversubscribed.
“The capital raising for $35 million is all done and came in early,” said a source close to the IPO that closed to investors in mid-December.
Chimeric Therapeutics initially intended to raise only $25m in its IPO, but according to the source, this target was raised by another $10m such was the interest from long-term institutional investors.
The company has developed a therapy treatment for solid tumours based on research at the City of Hope Cancer Centre in Los Angeles.
Sector: Consumer Discretionary
Year: 2019
Deal Type: Placement
Raise Amount: $2.2m
Price Change: $0.046 Unchanged
Sector: Consumer Discretionary
Year: 2018, 2019
Deal Type: Seed, Bridging and IPO
Raise Amount: $10m
Price Change: $0.13 Unchanged
Sector: Technology
Year: 2018
Deal Type: Seed and IPO
Raise Amount: $10m
Price Change: $0.074 -3.90%
Sector: Mining
Year: 2017
Deal Type: Seed & IPO
Raise Amount: $5m
Price Change: $0.26 +13.33%
Sector: Mining
Year: 2017
Deal Type: IPO & Placement
Raise Amount: $6m
Price Change: $0.054 +1.89%
Sector: Healthcare Equipment and Services
Year: 2016
Deal Type: IPO
Raise Amount: $8m
Price Change: $0.095 -3.06%
Sector: Materials
Year: 2016
Deal Type: IPO
Raise Amount: $9m
Price Change: $0.033 +3.12%
Sector: Biotechnology
Year: 2015, 2017, 2018
Deal Type: Placements & IPO
Raise Amount: $5m
Price Change: $2.43 +1.67%
Sector: Media an Entertainment
Year: 2016
Deal Type: Reverse Takeover
Raise Amount: $4m
Price Change: $0.037 Unchanged
Sector: Mining
Year: 2018, 2019, 2020
Deal Type: Placements & Rights Offer
Raise Amount: $1.5m
Price Change: $0.0090 -10.00%
Sector: Discretionary
Year: 2020
Deal Type: Placement
Raise Amount: $1.3m
Price Change: $0.070 -6.67%
Sector: Gaming
Year: 2020
Deal Type: Placement
Raise Amount: $1.25m
Price Change: $0.13 -3.70%
Sector: Mining (Gold)
Year: 2020
Deal Type: Placement
Raise Amount: $982k
Sector: Mining (Gold/Silver)
Year: 2020
Deal Type: Placement
Raise Amount: $2.3m
Price Change: $0.012 Unchanged
Sector: Hemp & CBD
Year: 2020
Deal Type: Pre IPO
Raise Amount: $2.5m
Sector: Psychedelic assisted therapy
Year: 2020
Deal Type: Placement
Raise Amount: $2.5m
Price Change: CAD $0.125 Unchanged
Sector: Mining
Year: 2020
Deal Type: Placement
Raise Amount: $330k
Price Change: 0.047 +11.90%
If you would like more information on future Peak deals, please don’t hesitate to get in touch.
